Clinical Trial Update: CAR-T Cell Therapy Combined With Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating a combination of CAR-T cell therapy with an allogeneic hematopoietic stem cell transplant for relapsed or refractory mult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CAR-T cell therapy

Snippet

Sponsor: Xuzhou Medical University | Conditions: Multiple Myeloma | Phase 1 | Status: NOT_YET_RECRUITING